Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1987 1
1989 2
1991 2
1992 4
1993 9
1994 9
1995 17
1996 9
1997 6
1998 7
1999 8
2000 6
2001 1
2002 9
2003 10
2004 7
2005 4
2006 9
2007 6
2008 10
2009 13
2010 12
2011 11
2012 13
2013 17
2014 17
2015 14
2016 18
2017 30
2018 34
2019 35
2020 29
2021 38
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

380 results
Results by year
Filters applied: . Clear all
Page 1
Targeting the p300/CBP Axis in Lethal Prostate Cancer.
Welti J, Sharp A, Brooks N, Yuan W, McNair C, Chand SN, Pal A, Figueiredo I, Riisnaes R, Gurel B, Rekowski J, Bogdan D, West W, Young B, Raja M, Prosser A, Lane J, Thomson S, Worthington J, Onions S, Shannon J, Paoletta S, Brown R, Smyth D, Harbottle GW, Gil VS, Miranda S, Crespo M, Ferreira A, Pereira R, Tunariu N, Carreira S, Neeb AJ, Ning J, Swain A, Taddei D; SU2C/PCF International Prostate Cancer Dream Team, Schiewer MJ, Knudsen KE, Pegg N, de Bono JS. Welti J, et al. Among authors: gil vs. Cancer Discov. 2021 May;11(5):1118-1137. doi: 10.1158/2159-8290.CD-20-0751. Epub 2021 Jan 11. Cancer Discov. 2021. PMID: 33431496 Free PMC article.
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.
Calcinotto A, Spataro C, Zagato E, Di Mitri D, Gil V, Crespo M, De Bernardis G, Losa M, Mirenda M, Pasquini E, Rinaldi A, Sumanasuriya S, Lambros MB, Neeb A, Lucianò R, Bravi CA, Nava-Rodrigues D, Dolling D, Prayer-Galetti T, Ferreira A, Briganti A, Esposito A, Barry S, Yuan W, Sharp A, de Bono J, Alimonti A. Calcinotto A, et al. Among authors: gil v. Nature. 2018 Jul;559(7714):363-369. doi: 10.1038/s41586-018-0266-0. Epub 2018 Jun 27. Nature. 2018. PMID: 29950727 Free PMC article.
Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors.
Neeb A, Herranz N, Arce-Gallego S, Miranda S, Buroni L, Yuan W, Athie A, Casals T, Carmichael J, Rodrigues DN, Gurel B, Rescigno P, Rekowski J, Welti J, Riisnaes R, Gil V, Ning J, Wagner V, Casanova-Salas I, Cordoba S, Castro N, Fenor de la Maza MD, Seed G, Chandran K, Ferreira A, Figueiredo I, Bertan C, Bianchini D, Aversa C, Paschalis A, Gonzalez M, Morales-Barrera R, Suarez C, Carles J, Swain A, Sharp A, Gil J, Serra V, Lord C, Carreira S, Mateo J, de Bono JS. Neeb A, et al. Among authors: gil v. Eur Urol. 2021 Feb;79(2):200-211. doi: 10.1016/j.eururo.2020.10.029. Epub 2020 Nov 8. Eur Urol. 2021. PMID: 33176972 Free article.
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.
Alajati A, D'Ambrosio M, Troiani M, Mosole S, Pellegrini L, Chen J, Revandkar A, Bolis M, Theurillat JP, Guccini I, Losa M, Calcinotto A, De Bernardis G, Pasquini E, D'Antuono R, Sharp A, Figueiredo I, Nava Rodrigues D, Welti J, Gil V, Yuan W, Vlajnic T, Bubendorf L, Chiorino G, Gnetti L, Torrano V, Carracedo A, Camplese L, Hirabayashi S, Canato E, Pasut G, Montopoli M, Rüschoff JH, Wild P, Moch H, De Bono J, Alimonti A. Alajati A, et al. Among authors: gil v. J Clin Invest. 2020 May 1;130(5):2435-2450. doi: 10.1172/JCI131133. J Clin Invest. 2020. PMID: 32250342 Free PMC article.
Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer.
Di Mitri D, Mirenda M, Vasilevska J, Calcinotto A, Delaleu N, Revandkar A, Gil V, Boysen G, Losa M, Mosole S, Pasquini E, D'Antuono R, Masetti M, Zagato E, Chiorino G, Ostano P, Rinaldi A, Gnetti L, Graupera M, Martins Figueiredo Fonseca AR, Pereira Mestre R, Waugh D, Barry S, De Bono J, Alimonti A. Di Mitri D, et al. Among authors: gil v. Cell Rep. 2019 Aug 20;28(8):2156-2168.e5. doi: 10.1016/j.celrep.2019.07.068. Cell Rep. 2019. PMID: 31433989 Free PMC article.
Response.
Miró Ò, Gil V. Miró Ò, et al. Among authors: gil v. Chest. 2018 Mar;153(3):766. doi: 10.1016/j.chest.2018.01.004. Chest. 2018. PMID: 29519306 No abstract available.
COVID-19 and cardiovascular comorbidities: An update.
Teixeira R, Santos M, Gil V. Teixeira R, et al. Among authors: gil v. Rev Port Cardiol (Engl Ed). 2020 Aug;39(8):417-419. doi: 10.1016/j.repc.2020.06.013. Epub 2020 Jul 9. Rev Port Cardiol (Engl Ed). 2020. PMID: 32718858 Free PMC article. No abstract available.
The burden of atherosclerosis in Portugal.
Costa J, Alarcão J, Araujo F, Ascenção R, Caldeira D, Fiorentino F, Gil V, Gouveia M, Lourenço F, Mello E Silva A, Sampaio F, Vaz Carneiro A, Borges M. Costa J, et al. Among authors: gil v. Eur Heart J Qual Care Clin Outcomes. 2021 Mar 15;7(2):154-162. doi: 10.1093/ehjqcco/qcaa060. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 32946553 Free PMC article.
Cardiac intensive care in Portugal: The time for change.
Monteiro S, Timóteo AT, Caeiro D, Silva M, Tralhão A, Guerreiro C, Silva D, Aguiar C, Santos J, Monteiro P, Gil V, Morais J. Monteiro S, et al. Among authors: gil v. Rev Port Cardiol (Engl Ed). 2020 Jul;39(7):401-406. doi: 10.1016/j.repc.2020.04.007. Epub 2020 Jul 15. Rev Port Cardiol (Engl Ed). 2020. PMID: 32680655 Free article. Review. English, Portuguese.
380 results